LD-2 disclosure · 2nd Quarter - Report
PHRMA
Client
- Name
- PHRMA
- Location
- * Undetermined
Registrant
- Description
- Government affairs and strategic consulting services
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesTrade (domestic/foreign)
Issues related to intellectual property protection, enforcement, and market access within trade negotiations; supply chain management; China; Issues related to global health; and issues related to tariffs.
LobbyistsRICH THOMAS · KIMBERLY ELLIS
TargetedSENATE · HOUSE OF REPRESENTATIVES
Foreign Relations
Issues related to intellectual property protection, enforcement, and market access within trade negotiations; supply chain management; China; issues related to global health; and issues related to tariffs.
LobbyistsRICH THOMAS · KIMBERLY ELLIS
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
Medicare Part D, Medicare Part B Issues, Importation of Drugs; H.R. 1, the One Big Beautiful Bill Act; H.R. 1492, S. 832, the EPIC Act; Medicare IRA implementation, Drug Premium Stabilization Program. Drug pricing, reimbursement and coverage related to MFN including CMMI models, 340B, IRA maximum fair price, ASP. PBM Reform included in H.R. 7194, the Consolidated Appropriations Act, the Department of Labor proposed PBM rule. Affordability and patient access issues; EPIC
LobbyistsJOEL WHITE